NUCLEOLIN and acute myeloid leukemia: Pre-clinical studies demonstrating that AS1411 targets cell-membrane nucleolin in leukemia cells [183] and results in cell death for acute myeloid leukemia (AML) cell lines [184] indicated its efficacy in hematologic malignancies as well.